Condensed Consolidated Statements of Operations (USD $)	0 Months Ended	3 Months Ended	6 Months Ended	3 Months Ended	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2014	Jun. 16, 2013 Resonant LLC	Jun. 16, 2013 Resonant LLC
OPERATING EXPENSES
Research and development expenses	$ 29,933	$ 968,807	$ 1,403,666	$ 78,566	$ 195,403
General and administrative expenses	750,421	454,632	976,547	12,965	135,993
Depreciation and amortization		62,003	75,344	2,575	4,905
TOTAL OPERATING EXPENSES	780,354	1,485,442	2,455,557	94,106	336,301
OPERATING LOSS	(780,354)	(1,485,442)	(2,455,557)	(94,106)	(336,301)
OTHER INCOME (EXPENSE)
Interest income	231	1,640	2,193
Interest expense	(169,104)	(2,098,832)	(2,807,862)	(145,190)	(199,961)
Fair value adjustments to warrant and derivative liabilities		(928,021)	(3,195,387)
Bridge warrant expense	(312,486)				(247,669)
Other income		1,163,772	1,163,772
TOTAL OTHER EXPENSE	(481,359)	(1,861,441)	(4,837,284)	(145,190)	(447,630)
LOSS BEFORE INCOME TAXES	(1,261,713)	(3,346,883)	(7,292,841)	(239,296)	(783,931)
Provision for income taxes			(800)	(800)	(800)
NET LOSS	$ (1,261,713)	$ (3,346,883)	$ (7,293,641)	$ (240,096)	$ (784,731)
NET LOSS PER SHARE - BASIC AND DILUTED (in dollars per share)	$ (1.26)	$ (0.81)	$ (2.37)
Weighted average shares outstanding-basic and diluted (in shares)	999,999	4,136,954	3,074,379